Financial Management Professionals, Inc. Bristol Myers Squibb CO Transaction History

Financial Management Professionals, Inc.

$765 Million
Q1 2025

A detailed history of Financial Management Professionals, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 504 shares of BMY stock, worth $23,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares

504

Previous 402 25.37%

Holding current value

$23,612

Previous $22,000 36.36%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$53.9 - $63.11 $5,497 - $6,437	102 Added 25.37%	504 $30,000
Q4 2024 Jan 15, 2025	BUY	$51.92 - $59.94 $934 - $1,078	18 Added 4.69%	402 $22,000
Q3 2024 Oct 24, 2024	BUY	$39.66 - $51.75 $2,815 - $3,674	71 Added 22.68%	384 $20,000
Q2 2024 Jul 12, 2024	BUY	$40.25 - $52.99 $4,950 - $6,517	123 Added 64.74%	313 $13,000
Q1 2024 Apr 16, 2024	SELL	$47.98 - $54.4 $3,886 - $4,406	-81 Reduced 29.89%	190 $10,000
Q4 2023 Jan 12, 2024	SELL	$48.48 - $57.85 $161,050 - $192,177	-3,322 Reduced 92.46%	271 $14,000
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $27,381 - $30,617	-473 Reduced 11.63%	3,593 $209,000
Q2 2023 Jul 10, 2023	SELL	$63.71 - $70.74 $84,224 - $93,518	-1,322 Reduced 24.54%	4,066 $260,000
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $63,147 - $71,623	961 Added 21.71%	5,388 $373,000
Q4 2022 Jan 11, 2023	BUY	$68.48 - $81.09 $34,171 - $40,463	499 Added 12.7%	4,427 $319,000
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $190 - $112,416	-1,463 Reduced 27.14%	3,928 $279,000
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $16,121 - $17,755	222 Added 4.29%	5,391 $415,000
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $176,201 - $211,281	2,866 Added 124.45%	5,169 $378,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $1,555 - $1,813	-29 Reduced 1.24%	2,303 $144,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $7,337 - $8,594	124 Added 5.62%	2,332 $138,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $15,353 - $16,720	248 Added 12.65%	2,208 $148,000
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $32,518 - $36,573	548 Added 38.81%	1,960 $124,000
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $5,543 - $6,281	-96 Reduced 6.37%	1,412 $88,000
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $402 - $445	7 Added 0.47%	1,508 $91,000
Q2 2020 Jul 21, 2020	BUY	$54.82 - $64.09 $67,099 - $78,446	1,224 Added 441.88%	1,501 $88,000
Q1 2020 Apr 24, 2020	SELL	$46.4 - $67.43 $2,366 - $3,438	-51 Reduced 15.55%	277 $15,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $6,249 - $8,152	127 Added 63.18%	328 $21,000
Q3 2019 Oct 11, 2019	BUY	$42.77 - $50.71 $2,181 - $2,586	51 Added 34.0%	201 $10,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $8,284 - $9,561	150	150 $9,000

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.

Account

Financial Management Professionals, Inc. Bristol Myers Squibb CO Transaction History